GENEVA, April 7 -- DE NOVO BIOTHERAPEUTICS CO., LTD. (17F, S-Tower, 82 Saemunan-roJongno-guSeoul 03185), 주식회사 드노보 바이오테라퓨틱스 (서울특별시종로구새문안로 82, 에스타워 17층) filed a patent application (PCT/KR2025/015152) for "RECOMBINANT RNA MOLECULE HAVING IMPROVED TRANSLATION EFFICIENCY" on Sep 26, 2025. With publication no. WO/2026/071763, the details related to the patent application was published on Apr 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by ...